MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

The Unlikely Treatable A Case of Ataxia

V. Quintana, S. Bonilla, L. Carvajal, J. Nastasi Catanese, . , . (Cali, Colombia)

Meeting: 2025 International Congress

Keywords: Ataxia: Clinical features, Ataxia: Genetics, Coenzyme Q10

Category: Ataxia

Objective: To present the first reported Colombian case in a patient presenting COQ8A-ataxia with bilateral palpebral ptosis, who had a favorable response to CoQ10 supplementation after a 57-year diagnostic delay.

Background: COQ8A-ataxia is a rare autosomal recessive disorder characterized by early-onset slowly-progressive ataxia, which may be accompanied by epilepsy, and dystonia. It results from biallelic pathogenic loss-of-function variants in the COQ8A gene, which encodes a mitochondrial atypical kinase/ATPase essential for the integrity of the coenzyme Q10 (CoQ10) biosynthetic complex.

Method: A 67-year-old woman presented with progressive ataxia. Her symptoms began at age 10 with gait instability, dysarthria, and falls. Bilateral palpebral ptosis developed soon after. No significant medical history. Her parents were first cousins.

She exhibited bilateral palpebral ptosis, bilateral hypometric saccades, dysmetria, and dysdiadochokinesia. Her gait was ataxic. Reflexes were normal, with no abnormal movements or upper motor neuron signs.

Brain MRI revealed severe cerebellar atrophy (Figure 1). Initial laboratory tests were normal. Electromyography showed no abnormalities. A panel for spinocerebellar ataxias (1, 2, 3, 6, 7, 8, 10, 17) was negative. A broader ataxia panel identified a homozygous pathogenic variant in the COQ8A gene (NM_020247.4: c.1358del p.Leu453Argfs24*), consistent with autosomal recessive cerebellar ataxia due to primary coenzyme Q10 deficiency type 4. Treatment with CoQ10 supplementation was initiated, resulting in significant improvement (SARA: 8, previous 24).

Results: Discussion

COQ8A-ataxia is the most common form of primary CoQ10 deficiency. Its prevalence remains unknown; however, approximately 123 cases have been reported worldwide. We present the first case in Colombia, characterized by pure cerebellar ataxia and bilateral palpebral ptosis. The latter is an uncommon feature among reported cases and is more common in SCA28 and POLG-related disorders.

Our patient falls within the subset of individuals with favorable response to CoQ10 (50%) despite a 57-year diagnostic delay.

Conclusion: COQ8A-ataxia should be considered an important differential diagnosis in cases of slowly progressive childhood-onset cerebellar ataxia, both with and without additional clinical features. Timely diagnosis is crucial, as this disorder is treatable, and symptoms are potentially reversible with appropriate intervention.

To cite this abstract in AMA style:

V. Quintana, S. Bonilla, L. Carvajal, J. Nastasi Catanese, . , . . The Unlikely Treatable A Case of Ataxia [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/the-unlikely-treatable-a-case-of-ataxia/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/the-unlikely-treatable-a-case-of-ataxia/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley